Saturday 17 October 2026
Export HUM’s income statement to Excel — free account
Humana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
413.16
19.04
−4.41%
Follow HUM
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
7.13% | 6.95% | 6.20% | 6.81% | |
Piotroski F-Score |
8 | 6 | 6 | 6 | |
| 2.59% | 2.49% | 2.13% | 2.38% | ||
ROIC |
20.47% | 16.56% | 14.31% | 17.52% | |
Return on Tangible Assets |
6.85% | 6.38% | 6.03% | 6.67% | |
Average Days of Receivables |
7.75 | 9.20 | 13.88 | 14.27 | |
Free Cash Flow per Share |
12.92 | 3.30 | 10.76 | 16.42 | |
Free Cash Flow |
1,554.00 | 398.00 | 1,295.00 | 1,972.00 | |
Capital Expenditures |
(491.00) | (523.00) | (549.00) | (567.00) | |
| Other line items | |||||
Cash ROIC |
2.91% | 0.80% | 2.37% | 3.44% | |
Accounts Receivable Turnover |
52.35 | 43.41 | 28.36 | 28.57 | |
Accounts Payable Turnover |
18.80 | 20.19 | 19.81 | 19.58 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
18.74 | 18.83 | 20.20 | 21.07 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.17) | (0.16) | (0.16) | (0.18) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.20% | 0.19% | 0.18% | 0.17% | |
Interest Coverage |
4.57 | 4.29 | 3.68 | 3.84 | |
Operating CF/Net income |
1.58 | 0.78 | 1.63 | 1.99 | |
Depreciation/Fixed assets |
0.38 | 0.37 | 0.37 | 0.37 | |
Capex/Depreciation |
(0.56) | (0.63) | (0.68) | (0.73) | |
Revenue per Share |
1,050.63 | 1,076.46 | 1,140.18 | 1,213.32 | |
Operating CF per Share |
17.00 | 7.65 | 15.32 | 21.15 | |
Capex per Share |
(4.08) | (4.34) | (4.56) | (4.72) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates